CD71-Specific Aptamer Conjugated with Monomethyl Auristatin E for the Treatment of Uveal Melanoma

Unlocking the potential of antibody–drug conjugates for cancer therapy

(2021) Joshua Z. Drago et al.   Nature Reviews Clinical Oncology

An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy

(2021) Juliana T. W. Tong et al.   MOLECULES

Uveal melanoma

(2020) Martine J. Jager et al.   Nature Reviews Disease Primers

Antibody-Drug Conjugates: The New Frontier of Chemotherapy

(2020) Sara Ponziani et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Antibody–Drug Conjugates for Cancer Therapy

(2020) Umbreen Hafeez et al.   MOLECULES

Iron: An Essential Element of Cancer Metabolism

(2020) Myriam Y. Hsu et al.   Cells

Elucidation and Structural Modeling of CD71 as a Molecular Target for Cell-Specific Aptamer Binding

(2019) Xiaoqiu Wu et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types

(2019) Monique K. van der Kooij et al.   Cancers

Bispecific Aptamer Induced Artificial Protein-Pairing: A Strategy for Selective Inhibition of Receptor Function

(2019) Liping Wang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Oncogenic signaling in uveal melanoma

(2018) John J. Park et al.   Pigment Cell & Melanoma Research

Tunable cytotoxic aptamer–drug conjugates for the treatment of prostate cancer

(2018) Bethany Powell Gray et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers

(2018) Christina Kratschmer et al.   Molecular Therapy-Nucleic Acids

Molecular Recognition and In-Vitro-Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer

(2018) Hui Zhang et al.   Molecular Therapy-Nucleic Acids

The transferrin receptor: the cellular iron gate

(2017) Elena Gammella et al.   Metallomics

A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer

(2017) Fangfei Li et al.   Nature Communications

Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients

(2017) Christopher J. Greene et al.   Oncotarget

Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth

(2017) Sorah Yoon et al.   Molecular Therapy-Nucleic Acids

Metastatic disease from uveal melanoma: treatment options and future prospects

(2016) Richard D Carvajal et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Uveal melanoma: From diagnosis to treatment and the science in between

(2016) Chandrani Chattopadhyay et al.   CANCER

Antibody–drug conjugates for cancer therapy

(2016) Anish Thomas et al.   LANCET ONCOLOGY

Nanomedicine in the application of uveal melanoma

(2016)   International Journal of Ophthalmology

Antibody-drug conjugates: recent advances in conjugation and linker chemistries

(2016) Kyoji Tsuchikama et al.   Protein & Cell

Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems

(2015) Feng Jiang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition

(2015) Xiaoqiu Wu et al.   Theranostics

Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy

(2014) Stephanie Tortorella et al.   JOURNAL OF MEMBRANE BIOLOGY

Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics

(2014) Baby Santosh et al.   Biomed Research International

Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy

(2014) Hongguang Sun et al.   Molecular Therapy-Nucleic Acids

Uveal melanoma

(2012) Francesco Spagnolo et al.   CANCER TREATMENT REVIEWS

Generating Aptamers by Cell-SELEX for Applications in Molecular Medicine

(2012) Mao Ye et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

An RNA Alternative to Human Transferrin: A New Tool for Targeting Human Cells

(2012) Samantha E Wilner et al.   Molecular Therapy-Nucleic Acids

Aberrant Expression of TfR1/CD71 in Thyroid Carcinomas Identifies a Novel Potential Diagnostic Marker and Therapeutic Target

(2011) Gaetano Magro et al.   THYROID